Baxter (BAX) Misses Q2 EPS by 2c; offers guidance
Get Alerts BAX Hot Sheet
Price: $24.35 --0%
EPS Growth %: -24.6%
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
NRIX, VFS, GLDG, More
EPS Growth %: -24.6%
Financial Fact:
Research and development expenses: 159M
Today's EPS Names:
NRIX, VFS, GLDG, More
Join SI Premium – FREE
Baxter (NYSE: BAX) reported Q2 EPS of $0.59, $0.02 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $2.82 billion.
GUIDANCE:
Baxter sees Q3 2025 EPS of $0.58-$0.62, versus the consensus of $0.64.
Baxter sees FY2025 EPS of $2.42-$2.52, versus the consensus of $2.52.
For earnings history and earnings-related data on Baxter (BAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Strong Buy
- Skyward Specialty Insurance Group (SKWD) Reiterated at Market Outperform by Citizens
- Slide Insurance Holdings (SLDE) PT Raised to $28 at Citizens
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share